Ligand Pharmaceuticals (NASDAQ:LGND) announced on Monday, April 27, 2026, that it has entered into a definitive agreement to acquire XOMA Royalty for $39 per share in cash.
The Real Brokerage (NASDAQ:REAX) and RE/MAX Holdings (NYSE:RMAX) announced on Monday, April 27, 2026, a definitive agreement for Real to acquire RE/MAX Holdings.
Clearmind Medicine (NASDAQ:CMND) announced on Monday, April 27, 2026, that it is evaluating its lead drug candidate, CMND-100 (MEAI), for a potential FDA Breakthrough Therapy Designation (BTD).
Shell (NYSE:SHEL) announced on Monday, April 27, 2026, that it has reached a definitive agreement to acquire Canadian energy leader ARC Resources in a transaction valued at approximately $16.4 billion, including debt.
Sierra Bancorp (NASDAQ:BSRR), the parent company of Bank of the Sierra, announced strong unaudited financial results for the first quarter of 2026 on Monday, reporting a 47% increase in diluted earnings per share compared to the same period last year.
Repay Holdings (NASDAQ:RPAY) released preliminary, unaudited financial results for the first quarter of 2026 on Monday, April 27, while simultaneously raising its full-year profitability outlook.
Business First Bancshares (NASDAQ:BFST), the parent company of b1BANK, reported its first-quarter 2026 financial results on Monday, highlighting a period of significant expansion following its recent merger activity.
Bank of Marin Bancorp (NASDAQ:BMRC) reported a strong return to profitability for the first quarter of 2026 on Monday, posting net income of $8.5 million.
Johnson & Johnson (NYSE:JNJ) announced on Monday that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the supplemental Biologics License Application (sBLA) for IMAAVY (nipocalimab-aahu).
AbbVie (NYSE:ABBV) announced on Monday, April 27, 2026, that it has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for SKYRIZI (risankizumab-rzaa).
Norwood Financial (NASDAQ:NWFL), the parent company of Wayne Bank, announced its financial results for the first quarter of 2026 on Monday, a period defined by the successful closing and integration of Presence Bancshares.
Thermo Fisher Scientific (NYSE:TMO) announced on Monday that it has entered into a definitive agreement to sell its microbiology business to Astorg, a prominent pan-European private equity firm.
